How Women Feel About an Over-the-Counter Birth Control Pill Most potential consumers were excited by the prospect, though sticker price and safety were lingering concerns.
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
Officials Balked at a Drug Company’s Tax Shelter. Auditors Approved It Anyway. Court documents show the potential conflicts of interest when accounting firms simultaneously help clients avoid taxes and audit their finances.
Baby Formula Shortage Has an Aggravating Factor: Few Producers With just a handful of companies making U.S. infant formula, a shutdown of Abbott’s plant had outsized impact on the supply.